Silan Coşkun, Uzun Ozge, Comunoğlu Nil Ustündağ, Gokçen Sanem, Bedirhan Selma, Cengiz Müjgan
Department of Pharmacology, Faculty of Medicine, Düzce University, Türkiye.
Biol Pharm Bull. 2007 Jan;30(1):79-83. doi: 10.1248/bpb.30.79.
In this study, we aimed to investigate the possible protective effect of resveratrol on gentamicin induced nephrotoxicity. Experiments were carried out in male Wistar rats weighing 200-250 g. Gentamicin sulfate (80 mg/kg per day i.p.), resveratrol (10 mg/kg per day i.p.) and gentamicin together with resveratrol were administered for 6 d. The animals were sacrificed 24 h after the last injection. Urine, blood samples and tissue samples were collected from the animals on the seventh day of the treatment before they were sacrificed. Kidneys were collected for histopathological studies and fixed in 10% buffered formalin solution. Tissue samples were stored at -70 degrees C in liquid nitrogen for the determination of glutathione (GSH), glutathione-S-transferase (GST), malondialdehyde (MDA) and catalase (CAT). Glutathione assay was determined by the method of Beutler et al. GST amounts were measured by the method of Habig et al. Catalase activity was tested by Aebi's method and MDA was determined according to Thayer's method. Blood urea level was significantly increased in the gentamicin treated group. The study showed lowered levels of urea and creatinine levels in resveratrol administered groups when compared with gentamicin administered rats, and the difference was statistically significant. It has been determined that resveratrol caused statistically significant decrease in lipid peroxidation and reduced the level of catalase. Histopathological examination showed that resveratrol prevented partly gentamicin induced tubular damage. The results histopathologically demonstrated that resveratrol has a protective effect against gentamicin induced nephrotoxicity, lipid peroxidation and cellular damage in rats.
在本研究中,我们旨在探究白藜芦醇对庆大霉素诱导的肾毒性可能具有的保护作用。实验选用体重为200 - 250克的雄性Wistar大鼠进行。硫酸庆大霉素(每天腹腔注射80毫克/千克)、白藜芦醇(每天腹腔注射10毫克/千克)以及庆大霉素与白藜芦醇联用,给药6天。在最后一次注射后24小时处死动物。在处死动物前,于治疗的第七天采集动物的尿液、血液样本和组织样本。采集肾脏用于组织病理学研究,并固定于10%的缓冲甲醛溶液中。组织样本储存在液氮中,温度为 -70摄氏度,用于测定谷胱甘肽(GSH)、谷胱甘肽 - S - 转移酶(GST)、丙二醛(MDA)和过氧化氢酶(CAT)。谷胱甘肽测定采用Beutler等人的方法。GST含量通过Habig等人的方法测量。过氧化氢酶活性通过Aebi的方法检测,MDA根据Thayer的方法测定。庆大霉素治疗组的血尿素水平显著升高。研究表明,与给予庆大霉素的大鼠相比,给予白藜芦醇的组中尿素和肌酐水平降低,且差异具有统计学意义。已确定白藜芦醇使脂质过氧化产生统计学显著下降,并降低了过氧化氢酶水平。组织病理学检查表明,白藜芦醇部分预防了庆大霉素诱导的肾小管损伤。组织病理学结果表明,白藜芦醇对大鼠庆大霉素诱导的肾毒性、脂质过氧化和细胞损伤具有保护作用。